Alessio Aghemo
Alessio Aghemo
Humanitas University
Verified email at hunimed.eu
TitleCited byYear
EASL clinical practice guidelines: management of hepatitis C
A Craxì, G Dusheiko, R Flisiak
J hepatol 55 (2), 245-264, 2011
1955*2011
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
R D'Ambrosio, A Aghemo, MG Rumi, G Ronchi, MF Donato, V Paradis, ...
Hepatology 56 (2), 532-543, 2012
2652012
Randomized study of peginterferon-α2a plus ribavirin vs peginterferon-α2b plus ribavirin in chronic hepatitis C
MG Rumi, A Aghemo, GM Prati, R D'Ambrosio, MF Donato, R Soffredini, ...
Gastroenterology 138 (1), 108-115, 2010
2562010
Patatin‐like phospholipase domain‐containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C
L Valenti, MG Rumi, E Galmozzi, A Aghemo, B Del Menico, S De Nicola, ...
Hepatology 53 (3), 791-799, 2011
2292011
EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version)
CF Dietrich, J Bamber, A Berzigotti, S Bota, V Cantisani, L Castera, ...
Ultraschall in der Medizin-European Journal of Ultrasound 38 (04), e16-e47, 2017
2152017
EASL recommendations on treatment of hepatitis C 2014.
European Association for The Study of The Liver
Journal of hepatology 61 (2), 373, 2014
2042014
EASL recommendations on treatment of hepatitis C 2015
JM Pawlotsky, A Aghemo, D Back, G Dusheiko, X Forns, M Puoti, ...
J hepatol 63 (1), 199-236, 2015
1672015
Genetic variation in the interleukin28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection
F Marabita, A Aghemo, S De Nicola, MG Rumi, C Cheroni, R Scavelli, ...
Hepatology 54 (4), 1127-1134, 2011
1442011
Recommendations for the management of hepatitis C virus infection among people who inject drugs
J Grebely, G Robaeys, P Bruggmann, A Aghemo, M Backmund, ...
International Journal of Drug Policy 26 (10), 1028-1038, 2015
1322015
New horizons in hepatitis C antiviral therapy with direct‐acting antivirals
A Aghemo, R De Francesco
Hepatology 58 (1), 428-438, 2013
1272013
Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method
A Tripodi, M Primignani, L Lemma, V Chantarangkul, A Dell'Era, ...
Hepatology 52 (1), 249-255, 2010
1262010
A review of the treatment of chronic hepatitis C virus infection in cirrhosis
E Vezali, A Aghemo, M Colombo
Clinical therapeutics 32 (13), 2117-2138, 2010
1172010
Trunnionosis: a pain in the neck
PS Pastides, M Dodd, KM Sarraf, CA Willis-Owen
World journal of orthopedics 4 (4), 161, 2013
113*2013
Treatment with ledipasvir–sofosbuvir for 12 or 24 weeks in kidney transplant recipients with chronic hepatitis C virus genotype 1 or 4 infection: a randomized trial
M Colombo, A Aghemo, H Liu, J Zhang, H Dvory-Sobol, R Hyland, C Yun, ...
Annals of internal medicine 166 (2), 109-117, 2017
1102017
Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy
J Iwamoto, Y Saito, A Honda, Y Matsuzaki
World Journal of Gastroenterology: WJG 19 (11), 1673, 2013
99*2013
The diagnostic accuracy of Fibroscan® for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response
R D’Ambrosio, A Aghemo, M Fraquelli, MG Rumi, MF Donato, V Paradis, ...
Journal of hepatology 59 (2), 251-256, 2013
982013
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4
S De Nicola, A Aghemo, M Grazia Rumi, E Galmozzi, L Valenti, ...
Hepatology 55 (2), 336-342, 2012
972012
Hepatitis C virus treatment in the real world: optimising treatment and access to therapies
F Zoulim, TJ Liang, AL Gerbes, A Aghemo, S Deuffic-Burban, G Dusheiko, ...
Gut 64 (11), 1824-1833, 2015
952015
Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management
M Viganò, E Degasperi, A Aghemo, P Lampertico, M Colombo
Expert opinion on biological therapy 12 (2), 193-207, 2012
862012
Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C
A Aghemo, GM Prati, MG Rumi, R Soffredini, R D'Ambrosio, E Orsi, ...
Hepatology 56 (5), 1681-1687, 2012
832012
The system can't perform the operation now. Try again later.
Articles 1–20